M&A Deal Summary

Hologic Acquires Cytyc

On October 22, 2007, Hologic acquired medical products company Cytyc for 6.2B USD

Acquisition Highlights
  • This is Hologic’s 8th transaction in the Medical Products sector.
  • This is Hologic’s largest (disclosed) transaction.
  • This is Hologic’s 7th transaction in the United States.
  • This is Hologic’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2007-10-22
Target Cytyc
Sector Medical Products
Buyer(s) Hologic
Deal Type Add-on Acquisition
Deal Value 6.2B USD

Target

Cytyc

Marlborough, Massachusetts, United States
Cytyc Corp, is a design, development, manufacture, and marketing of clinical products that focus on women’s health.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Hologic

Marlborough, Massachusetts, United States
Category Company
Founded 1985
Sector Medical Products
Employees6,944
Revenue 4.0B USD (2023)
DESCRIPTION
Hologic's corporate headquarters in Marlborough, Massachusetts.
Hologic's corporate headquarters in Marlborough, Massachusetts.

Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world. Hologic was formed in 1985 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 8 of 25
Sector (Medical Products) 8 of 19
Type (Add-on Acquisition) 7 of 23
State (Massachusetts) 1 of 3
Country (United States) 7 of 18
Year (2007) 2 of 2
Size (of disclosed) 1 of 24
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-09-19 BioLucent

Aliso Viejo, California, United States

BioLucent LLC is a women’s health company dedicated to the early detection of breast cancer. BioLucent develops, markets and sells a breast cushion, MammoPad, to decrease the discomfort associated with mammography. BioLucent's primary research and development efforts are directed at its brachytherapy business which is focused on breast cancer therapy.

Buy $70M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-01-22 Hologic - Gestiva

United States

Hologic - Gestiva is a drug, which could be used in the prevention of preterm birth in pregnant women with a history of at least one spontaneous preterm birth.

Sell $82M
Mergr

Product

Company

Legal